A B S T R A C T We have attempted to measure the metabolic clearance rates (MCR) and the transfer factors of estradiol (E2) and estrone (El) during 2-hr and 12-hr infusions. When estradiol-3H was infused for 2 hr, apparent equilibrium was reached at 70 min; the 12-hr infusions showed that plasma estradiol-3H levels increased slowly throughout the infusion. When estrone-3H was infused, constancy of estrone-3H levels was not attained in either the 2-hr infusions or in the two 12-hr infusions. The tritium level in the metabolite of the infused estrogen did not become constant in 50% of the short infusions and increased during all the long infusions. Thus, the conversion ratios CE1E2 and CE2E1 continually changed and transfer factors could not be calculated.
INTRODUCTION
The concepts of metabolic clearance rate (1) and transfer factors for interconverting compounds (2, 3) have proved useful in the study of androgen metabolism (4, 5) . We have utilized the technique of constant infusion of radioactive tracers to study the clearance rates of estrone and estradiol and to estimate the extent of net interconversion or transfer factors. Although the preliminary results (6) were in substantial agreement Dr. Hembree's present address is Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York 10032.
Received for publication 14 February 1969 and in revised form 6 June 1969. with those of Longcope, Layne, and Tait (7) , our data suggested that constant levels of isotope were not always attained during these infusions. Since estimates of these parameters can be meaningful only when the steady-state requirement is met, we have examined in more detail the kinetics of estrone-estradiol metabolism.
The effect of such variables as mass of estrogen infused, length of infusion, and hormonal status on the metabolic clearance rate (MCR) was investigated.
METHODS Materials. Estrone-6-7-3H, estradiol-17,3-6,7-3H (34c/ mmole) (New England Nuclear Corp.), and estrone-4-14C (29 mc/mmole) and estradiol-17j3-4-14C (53.7 mc/mmole) (Nuclear-Chicago) were purified by thin-layer chromatography (TLC) and stored at 4°C. Aliquots of 1H-and 14C-labeled steroids were combined and radiochemical purity was demonstrated before use by constancy of the 3H/14C ratio through a series of derivatives (Fig. 1 ). Steroids obtained from Mann Research Labs Inc. were recrystalized before use in the reverse-isotope dilution studies. Solvents used for chromatography were redistilled before use and chemical reagents were used without further purification.
Chromatography. Merck precoated Silica Gel GF-254 20 X 20 cm glass plates were used for TLC. The systems used for each compound and the Rf values are given in Table I. Gas-liquid chromatography was performed with a Glowall Corporation model No. 310 using 3% SE-30 packing (Applied Science Laboratories Inc.) and a hydrogen flame detector. The height of the peak response was a linear function of the mass injected between 20 and 140 ng and 2 SE ranged between 2 and 3%.
Subjects. Normal subjects (Nos. , ages 21-30 yr, were hospitalized at the Clinical Center of the National Institutes of Health, and received no medications. Each woman had normal cyclic menses. The three normal postmenopausal women (Nos. 23, 24 , and 26) were aged 52, 53, and 67 yr, respectively, and received no medications. Patients (Nos. 25, 27, 28, 32, and 34) had metastatic carcinoma of the breast with normal kidney, hepatic, bone marrow, and endocrine function at the time of the study. A (5) . The total dose of radioactivity given was 30-40 yc of tritium or 4-5 luc of carbon-14. One-third of the total dose was given over a period of 2-3 min as a priming dose 30 min before the infusion was begun. 30-40 ml of blood was drawn in heparinized syringes at 50, 70, 90, and 120 min after starting the infusion; the plasma was separated immediately by centrifugation and was stored at -16C until extracted. In subject No. 34 the effect of intravenous administration of estradiol (E2) upon MCRE2 was evaluated. A sterile stock solution of estradiol (10 mg/ml) in propylene glycol was prepared by the pharmacy. The steroid was dissolved in ethanol and added to isotonic saline (to give a 5% ethanol solution). Estradiol was given continuously by infusion pump for 6 days. Each of three dose levels (17, 170 , and 1440 ,Ag/day) was infused for 48 hr. The MCRE2 was determined before, at the end of each dose, and the day after the 6 day infusion by a 2 hr infusion of E2-3H. Assuming no endogenous estrogen production, the plasma estrogen levels were calculated from the rate of estrogen infusion and the plasma estrogen radioactivity during the MCR study. The specific activity of each estradiol infusion was checked by gas-liquid chromatography and tritium measurement of ether extracts of the infusate and agreed well with the calculated specific activities.
Long infusions. In four subjects (Nos. 27, 28, 32, and 33) the infusion period was 8-12 hr. These subjects were given a total dose of 200-400,uc. Only patient No. 28 received a priming dose of 10 ,uc 30 min before the start of the infusion. Blood samples were obtained at hourly intervals, or more frequently, throughout the infusion period and patients remained supine except to use a bed pan. During the infusions patients were given a snack of tea and toast.
Extraction and derivative formation. 25 ml water and 150-200 jg of estrone (E1) and estradiol (E2) were added to each (8) . Samples were dried in 100-ml conical tubes, dissolved in 0.1 ml ethanol plus 25 ml of a 2.0% boric acid solution, and brought to pH 11.2 with 20% NaOH. After addition of 0.5 ml dimethyl sulfate, tubes were shaken vigorously and incubated at 37°C for 30 min. The incubation was repeated after the addition of 0.5 ml dimethyl sulfate and 1.0 ml 20% NaOH. Excess dimethyl sulfate was neutralized with 5.0 ml 20% NaOH and the reaction mixture was extracted with 50 ml petroleum ether, the organic phase transferred to a 50 ml conical tube and washed two times with 2 ml 0.1 M acetic acid. The yield after TLC of estrone-3-methyl ether was 85-95% and of 17j3-estradiol-3-methyl ether was 80-90%. Estrone-3-methyl ether was reduced with sodium borohydride. 17w-estradiol-3-methyl ethers were acetylated and oxidized with a partially purified 17-ol-dehydrogenase (9) . The yields of each derivative were 80-90%. Fig. 1 outlines the procedures followed to establish radiochemical purity of each plasma steroid. Radioactivity was measured in a Packard Tri-Carb liquid scintillation spectrometer, model 574, at a tritium efficiency of 27% and carbon-14 efficiency of 57%. 18% of the carbon- 14 counts were counted in the tritium channel.
Statistics and calculations. The 95% confidence limits of each 3H/14C ratio were calculated as described in the Appendix. When the ratios of the three derivatives did not differ significantly, the average was used in subsequent calculations. Otherwise the lowest 3H/14C ratio was assumed to be the final one. In 89% of the samples, 3H/14C did not change after the first derivative, in 6% the last two 3H/14C ratios were the same and lower than the first, and in 2% the last 3H/14C of the third derivative was the highest. A fourth derivative confirmed the The symbols and other calculation are those used by Longratio of the third in each case. cope et al. (7); z refers to the isotope in E2, x to the isotope in
The 95% confidence limits of plasma 3H or 14C in the reverse E1, superscripts to the steroids, and subscripts to the compartisotope dilution studies were obtained by first assessing the ments. The formulas used are as follows: error of the isotope dilution procedure. When 10 samples of MCRES = RXEI/xE1 and MCRE2 = R E2/ZE2 identical specific activity were processed as in Fig. 1, 95% confidence I imits were 46%.
where RXEI and R3E2 are the infusion rates expressed as dis- When the tritium in the metabolite of the infused estrogen was examined, it could be seen that tritium levels did not become constant in all studies. In 10 of the 17 estrone infusions, constant tritium levels in estradiol were not attained (Tables II and III and Fig. 2 ). When the data from the entire group were analyzed, plasma tritium levels in estradiol during estrone-3H infusions were 1.19 ±0.09 at 70 min, 1.27 ±0.08 at 90 min, and 1.57 ±0.17 at 120 min taking the 50 min value as 1.00. Similarly, mean plasma tritium levels in estrone during estradiol-3H infusions were 1.22 40.12, 1.43 ±-0.11, and 1.66 ±0.14 at 70, 90, and 120 min, respectively (Table II, Fig. 2) . Mean values at 90 and 120 min were different from 1.00 in both groups and a significant trend was indicated. In 6 of the 12 estradiol infusions, constant tritium levels in plasma estrone levels were not reached (Tables II and III, Fig. 2) .
Long infusions. The data from the four studies are presented in Table IV . Only in patient No. 28 was a priming dose of 10 ,c given 30 min before the infusion. When estrone-3H was infused, constancy of plasma 3H levels in estrone was not maintained, although for 2-to 3-hr periods, there was apparent constancy of the isotope concentration (Fig. 3) . The tritium levels in the metabolite, estradiol, increased for 12 hr in patient No. 32 and for 9 hr in patient No. 33. In addition, the conversion ratios showed the same trend.
When estradiol-3H was infused (Fig. 4) there was a small but significant increase in plasma estradiol-3H Effect of mass on "metabolic clearance rates." "Metabolic clearance rates" were measured over a 2 hr period in three normal subjects infused with estrone and estradiol labeled either with 3H or 14C. 1 wk later, the studies were repeated but the labels were reversed. The "metabolic clearance rates" were the same (Table  V) whether 3H-or 14C_ labeled estrogens were used, although the mass of estrogen infused was 600-1000 times greater when the steroid-'4C was given. Approximately 25 ,ug of estradiol-14C and 50 jug of estrone-14C were infused for each study.
The effect of larger amounts of estradiol on the "MCRE2" and the conversion ratio ZEi/ZE3 was examined by giving a continuous infusion of estradiol at varying rates (Table VI) . The specific activity of each estradiol infusion was checked by gas-liquid chromatography of ether extracts of the solution and agreed well with the estimated specific activity. The "MCRE2" remained unchanged when 17 and 170 ,ug of E2 were infused daily. When the infusion rate was increased to 1440,ug/day, "MCRE2" increased 50%6. Similarly the conversion ratio was unchanged until the highest infusion rate was reached.
Altered hormonal status. likewise met during 2-hr infusions of estrone and estradiol. We found, however, that tritium levels in plasma estrone did not always become constant during 2-hr estrone-3H infusions and subsequently, 12-hr infusions confirmed that steady-state levels were not attained for at least 9 hr, and that plasma estrone levels at the end of long infusions could be significantly greater than those of the short infusions. A priming dose of the magnitude given before 2-hr studies would not have appreciably changed the tritium levels observed after two hours because of the rapid plasma half-time of estrone. The apparent conflict between these data and those of Longcope et al. (7) may be due to the shorter sampling interval and to the lesser amounts of isotope infused with correspondingly greater counting errors in their study.
It is possible to attach significance to an "MCR" calculated from data obtained during the first 2-hr of estrone-3H infusions? An unequivocal answer to this question is contingent upon elucidation of the reasons for the observed data. At least two possible explanations are consistent with the data: (a) that nonsteady-state metabolic processes play a major role in estrone clear- ance, or (b) that the reentry of estrone into the plasma is slow in comparison to its relatively rapid half-time. Steroid-dependent diurnal variation has been demonstrated for the hepatic transaminase system. Similar dependence of the steroid metabolizing enzyme systems could result in failure to reach a steady-state level during long constant infusions. Sandberg and Slaunwhite (13) reported that as much as 2% of the total radioactivity could be found in the blood as estrogen conjugate 48 hr after an injection of estrone-3H. In addition, as much as 50%' of the circulating estrogen potentially enters the enterohepatic circulation. Reentry of estrone into the plasma from either or both of these sources could also produce continually increasing plasma tritium levels in estrone. These alternative explanations are not exclusive, though the implications of each are quite different. Failure to have infused long enough to attain steady-state levels means that data from 2-hr infusions lead to an overestimate of the true MCR. On the other hand, lack of conformity to steady-state kinetics would raise serious doubts concerning the validity of a blood production rate calculated from constant infusion data. The wide discrepancy between estrone blood production rates (14) * In these studies the plasma isotope levels of infused steroid showed the same deviation from equilibrium as in normal subjects (Tables II and III). urinary metabolites (15, 16) may, in part, be explained by these methodologic considerations. In contrast to estrone, the tritium levels in estradiol usually became constant 70-120 min after the start of the infusion of estradiol-3H. However, with prolonged infusions, there was a slow rate of increase of plasma tritium levels so that the final plasma levels were significantly greater than the initial ones. Thus, the constant infusion technique probaly gives close to correct values for estradiol "MCR." The differences in the behavior between estrone and estradiol may be attributed to the suggested estrone conjugate pool. (Tables II and III. I Calculated from the mean zE2 and the specific activity infused. § Conversion fraction, E-±95%7( confidence limits (Appendix II).
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effect of reentry of estrone would be reflected to a much smaller extent in changes in plasma estradiol than in estrone because of the low rate of conversion of estrone to estradiol. The measurement of the transfer factor [p], the fraction of the production rate of a precursor steroid hormone that is converted to a blood or urinary metabolite, is necessary for the analysis of the origins of the steroid A number of methodologic difficulties have been raised by these studies which may be resolved by elucidation of the role of estrogen conjugates, the enterohepatic circulation and nonsteady-state parameters in the metabolism of estrogens. However, the agreement about the "estrogen MCR's" between two laboratories and the narrow range of values strongly suggest that this parameter measured during 2-hr infusions is reproducible in normal subjects and may be useful in the further study of estrogen metabolism. Therefore, we have made the subsequent comparisons of "estrogen clearance" based on data obtained from the conventional 2-hr infusions.
We have confirmed the previous report that " MCRE2" is significantly lower than the apparent MCREl (p 0.01). In addition, the "MCRE2" is lower in women than in men whereas there is no sex difference in the apparent ''MCREl". There is a strong similarity in the metabolism of these interconverting steroids with 17/3-hydroxy and 17-ketone functions to the metabolism of the analogous androgen pair, testosterone and androstenedione. Both testosterone (19) and estradiol (20) are bound to a specific plasma protein and the metabolic clearance rate of both is lower than that of androstenedione and estrone which are less strongly bound to plasma proteins. Further, with both estradiol and testosterone, the metabolic clearance rate is lower in women than in men (5) . Protein binding of testosterone is greater in women than in men and a similar difference has been suggested by the sex difference in the distribution of estradiol between red cells and plasma (7) . It is tempting to relate these differences in the clearance rate to differences in the degree of protein binding. However metabolic clearance rates are the composite of multiple chemical reaction rates and rates of transfer among compartments. Sex differences in the pattern of the urinary excretion of metabolites of estradiol have been noted (21, 22) . In androgen studies, Southren, Gordon, and Tochimoto (23) suggested that testosterone induced increases of metabolic clearance rates must be due, in part, to increased hepatic metabolism rather than changes only in plasma binding of testosterone.
If the sex differences observed in "MCRE2" are related to plasma estradiol levels, then the "MCRE2" might be higher in postmenopausal women than in normal menstruating women. Since the mean "MCRE2" of the six postmenopausal women did not differ from that of the younger women, no support was obtained for this hypothesis. The limited sample studied precludes any conjectures about such possibly important factors as length of time after the menopause and biologic age.
The minimal effects of acute changes in plasma estrogen concentrations on the "MCRE2" were apparent from those studies in which "MCRE2" was determined during infusions of varying amounts of estrogen. The data show that E2-14C can serve as an adequate tracer for "MCR" determination although the estradiol infusion rate was equivalent to 300 ug/24 hr. Similarly, the infusion of estradiol to produce estradiol levels of 7 ng/100 ml and 17 ng/100 ml comparable to those seen in normal men and women did not alter estradiol metabolic clearance rates. When the calculated plasma estradiol reached a concentration of 72 ng/100 ml, a level compatible with that of preganancy, "MCRE2" increased sharply and returned to normal 48 hr after cessation of the estrogen infusion. In contrast with these acute studies it might be anticipated that prolonged treatment with estrogens would decrease the "metabolic clearance" of estradiol since the metabolic clearance rates of both testosterone (23) Dexamethasone treatment of hirsute women produces a small but definite increase in testosterone metabolic clearance rates (24) . In the present study we have demonstrated a similar effect of glucocorticoid excess on "MCRE2'. The mechanism by which the clearance of testosterone and estradiol are altered by glucocorticoids is not understood. However, the study of the adrenalectomized woman indicates that this effect is a result of increased corticoid production rather than increased ACTH or adrenal androgen production. and the confidence limits are found analogous to that of CEIE2.
